← til store investorer
Ikarian Capital, LLC
kapitalforvalter · portefølje $928 mio. · 156 positioner · rapport pr. 30.06.2026
Aktiepositioner
Indlæser positioner…
I virksomheder i vores database 37
| Selskab | Andel | Aktier | Rapportdato |
|---|---|---|---|
| Spruce Biosciences, Inc. | 21.55% | 121 356 | 2026-06-30 |
| CNS Pharmaceuticals Inc | 9.29% | 135 830 | 2026-06-30 |
| Quince Therapeutics, Inc. | 7.39% | 72 251 | 2026-06-30 |
| Connect Biopharma Holdings L… | 7.21% | 4 538 534 | 2026-06-30 |
| Quoin Pharmaceuticals Ltd DR… | 6.78% | 211 538 | 2026-06-30 |
| Pelthos Therapeutics Inc. | 6.7% | 256 598 | 2026-06-30 |
| Lipocine Inc | 6.17% | 508 556 | 2026-06-30 |
| InMed Pharmaceuticals Inc | 4.46% | 245 025 | 2026-06-30 |
| Avenue Therapeutics Inc | 4.4% | 140 000 | 2024-12-31 |
| Alpha Cognition Inc | 3.84% | 836 259 | 2026-06-30 |
| Rein Therapeutics Inc | 3.42% | 2 950 000 | 2026-06-30 |
| Cumberland Pharmaceuticals I… | 3.36% | 503 153 | 2026-06-30 |
| ProQR Therapeutics BV | 3.25% | 3 425 930 | 2026-06-30 |
| Traws Pharma Inc | 3.11% | 478 142 | 2026-06-30 |
| Passage Bio Inc | 3.09% | 99 517 | 2026-06-30 |
| Kazia Therapeutics Limited | 3.06% | 396 201 | 2026-06-30 |
| Cardiol Therapeutics Inc Cla… | 2.8% | 3 325 000 | 2026-06-30 |
| ProMIS Neurosciences Inc. | 2.29% | 205 000 | 2026-06-30 |
| Enveric Biosciences Inc | 2.23% | 100 002 | 2026-06-30 |
| Tenax Therapeutics Inc | 1.73% | 787 600 | 2026-06-30 |
| Kalaris Therapeutics, Inc. | 1.51% | 360 000 | 2026-06-30 |
| Acumen Pharmaceuticals Inc | 1.46% | 1 053 797 | 2026-06-30 |
| Cue Biopharma | 1.44% | 104 364 | 2026-06-30 |
| Silence Therapeutics PLC | 1.38% | 830 784 | 2026-06-30 |
| Eupraxia Pharmaceuticals Inc… | 1.25% | 809 741 | 2026-06-30 |
| Vistagen Therapeutics, Inc. | 1.17% | 519 077 | 2026-06-30 |
| Ocugen Inc | 1.17% | 3 962 972 | 2026-06-30 |
| Journey Medical Corp | 1.13% | 251 436 | 2026-06-30 |
| Neuphoria Therapeutics Inc | 0.88% | 47 443 | 2026-06-30 |
| Evaxion Biotech AS | 0.83% | 74 698 | 2026-06-30 |
annonce
